Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician
9.8 Major clinical issues with eating disorders and inhalant/ solvent use
Table of contents
- Acknowledgments
- Abbreviations
- Preface
- Introduction
- Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician
1. Levels of evidence- 2. Management of people with comorbidity of mental disorders and substance use
- 3. The common drug groups
- 4. Tobacco
- 5. Depression and substance use
- 6. Anxiety disorders and substance use
- 7. Psychosis (schizophrenia and bipolar disorder) and substance use
- 8. Personality disorders and substance use
9. Eating disorders and substance use- 9.1 Eating disorders
- 9.2 Comorbidity with eating disorders
- 9.3 Major clinical issues with eating disorders and cannabis/ hallucinogen use
- 9.4 Major clinical issues with eating disorders and alcohol use
- 9.5 Major clinical issues with eating disorders and opioid use
- 9.6 Major clinical issues with eating disorders and stimulant (including methamphetamine) use
- 9.7 Major clinical issues with eating disorders and benzodiazepine use
- 9.8 Major clinical issues with eating disorders and inhalant/ solvent use
- 10. Somatoform disorders and substance use
- 11. Gambling and substance use
- 12. Brain injury, mental disorders and substance use
- 13. Bibliography
- 14. Appendices
- People with eating disorders do not commonly use inhalants or solvents.
- There is no literature that sheds light on managing people with comorbid eating disorders and problems relating to inhalant/solvent use.
9.8.1 Effects of inhalants/ solvents on eating disorders
- People with eating disorders do not commonly use inhalants or solvents(347).
9.8.2 Interactions between inhalants/ solvents and therapeutic agents for eating disorders
- Inhalants can exacerbate the sedative effects of some antidepressants including tricyclic antidepressants and mirtazepinex.
- Most antidepressants reduce seizure threshold and tricyclic antidepressants can cause cardiac arrhythmias. Therefore, risks should be appraised prior to commencementx.
9.8.3 Management approaches to comorbid eating disorders and inhalant/ solvent use
- There appears to be no literature that sheds light on managing people with comorbid eating disorders and problems relating to inhalant/solvent use.
- As with most other substances, inhalant users should be encouraged to try and reduce or cease use.
- In general with respect to inhalant/solvent use(65):
- Outline the harms associated with inhalant/solvent use.
- Investigate polysubstance use as this is common.
- Standard CBT approaches to both sets of issues should be used, with particular attention to the development of:
- Assertiveness skills (refusal skills).
- Coping skills for controlling and managing emotions such as anger and sadness.
- Offer alternatives to inhalant use, for example, recreational activities.
- Community reinforcement approaches should be developed by mobilising the local health and welfare service system in individual care plans.
- Family interventions need to be considered, for example, increasing communication between the person and the family.
- Assertive outreach and follow-up may be required.
